Eps Corp operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eps Corp with three other
miscellaneous service companies in Asia:
Takara Bio Inc
sales of 32.31 billion Japanese Yen [US$288.22 million]
of which 92%
was Bio support),
Chabiotech Co Ltd
of South Korea
(488.60 billion Korean Won [US$431.43 million]
of which 90%
was health care), and
Genscript Biotech Corp
based in Hong Kong
(1.81 billion Hong Kong Dollars [US$230.82 million]
of which 61%
was Bio-Science services and products).
Eps Corp reported sales of ¥65.77 billion (US$586.66 million)
September of 2018.
increase of 8.7%
versus 2017, when the company's sales were ¥60.48 billion.
Sales at Eps Corp have increased during each of the previous five years
(and since 2013, sales have increased a total of 75%).